Skip to main content
NASDAQ: FWBI
First Wave Bio

 

PRESS RELEASES
MEDIA

 

PRESS RELEASES

2023  
Title Date
First Wave BioPharma To Present at the BIO Investor Forum
15 September
First Wave BioPharma Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $4.0 Million Gross Proceeds Priced At-the-Market
14 September
First Wave BioPharma Announces Exclusive Global License Agreement for Capeserod from Sanofi
14 September
First Wave BioPharma to Participate in the H.C. Wainwright 25th Annual Global Investment Conference
05 September
First Wave BioPharma, Inc. Announces Pricing of $2.1 Million Public Offering
19 July
First Wave BioPharma Announces Initial Topline Results from Phase 2 SPAN Clinical Trial Investigating Enhanced Adrulipase Formulation
13 July
First Wave BioPharma Chairman and CEO Issues Letter to Stockholders
05 July
First Wave BioPharma Announces Final Patient Dosed in Phase 2 SPAN Clinical Trial of Enhanced Adrulipase Formulation
28 June
First Wave BioPharma Strengthens Intellectual Property Estate
27 June
First Wave BioPharma to Attend the 36th National Cystic Fibrosis Education Conference (July 28-30)
15 June
First Wave BioPharma Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $2.4 Million Gross Proceeds Priced At-the-Market
13 June
First Wave BioPharma Reaches Enrollment Target for Phase 2 SPAN Adrulipase Clinical Trial in Cystic Fibrosis
13 June
First Wave BioPharma CEO James Sapirstein to Present at 2023 BIO International Conference
15 May
First Wave BioPharma Completes Patient Screening For Phase 2 Span Adrulipase Clinical Trial in Cystic Fibrosis
11 May
First Wave Biopharma Exceeds 50% Enrollment Target for Phase 2 Span Adrulipase Clinical Trial in Cystic Fibrosis
25 April
First Wave BioPharma Announces $4.0 Million Private Placement Priced At-The-Market under Nasdaq Rules
13 March
First Wave BioPharma Announces Second Patient Dosed in Phase 2 SPAN Clinical Trial of Enhanced Adrulipase Formulation in Cystic Fibrosis
10 March
First Wave BioPharma Announces First Patient Dosed in Phase 2 SPAN Clinical Trial of Enhanced Adrulipase Formulation
09 March
First Wave BioPharma to Participate in ‘Fireside Chat’ at the 35th Annual Roth Conference
28 February
First Wave BioPharma Announces Phase 2 Adrulipase Combination Trial Data to be Presented at the 2023 Digestive Disease Week (DDW) Conference
21 February
First Wave BioPharma Chairman and CEO Issues Letter to Stockholders
13 February
First Wave BioPharma Regains Compliance With Nasdaq’s Minimum Bid Price Requirement
07 February
First Wave BioPharma Announces First Patient Screened for Phase 2 SPAN Adrulipase Trial in Cystic Fibrosis
02 February
First Wave BioPharma Announces Initiation of Phase 2 Trial Investigating Enhanced Adrulipase Formulation in Exocrine Pancreatic Insufficiency in Patients with Cystic Fibrosis
31 January
First Wave BioPharma to Present at the BIO CEO & Investor Conference
30 January
First Wave BioPharma Announces Expansion of Adrulipase Intellectual Property Portfolio
25 January
First Wave BioPharma to Present at Sequire Biotechnology Conference
24 January
First Wave BioPharma Provides Update on IND Filing For Phase 2 Trial of Enhanced Microgranule Formulation of Adrulipase for Exocrine Pancreatic Insufficiency
13 January
First Wave BioPharma Announces Results of Special Meeting of Stockholders
13 January
First Wave BioPharma Announces Adjournment of Special Meeting
09 January

 

2022

 

2021

 

2020

 

2019

 

2018

 

2017

 

2016

 

2015

 

2014

 

MEDIA

2023

 

TitleFormatDate
Benzinga: 'Transformative Event' For First Wave BioPharma: License Agreement for Hopeful Gastrointestinal Candidate From Sanofi Article 14 September
Endpoints News: First Wave licenses drug from Sanofi Article 14 September
Fierce Biotech: Sanofi Slings Long-Dormant Alzheimer’s Asset to First Wave for repurposing, secures buy back rights Article 14 September
Marketwatch: First Wave BioPharma stock soars in active trading after Sanofi license deal Article 14 September
Pharmaceutical Technology: First Wave plans to repurpose Sanofi’s capeserod as GI therapy Article 14 September
The Big Biz Show – Bob "Sully" Sullivan interviews James Sapirstein Video 22 August
The Big Biz Show – Bob "Sully" Sullivan interviews James Sapirstein Video 15 August
The Big Biz Show – Bob "Sully" Sullivan interviews James Sapirstein Video 16 June
Cystic Fibrosis News Today: Results from Phase 2 adrulipase trial for EPI expected next month Article 15 June
Cystic Fibrosis News Today: SPAN Phase 2 trial of adrulipase for EPI completes patient screening Article 15 May
The Big Biz Show – Bob “Sully” Sullivan interviews James Sapirstein Video 02 May
Cystic Fibrosis News Today: Phase 2 trial of adrulipase in treating EPI tops 50% enrollment goal Article 02 May
Global Business Reports: Interview with James Sapirstein Article 17 March
Cystic Fibrosis News Today: Dosing begins in trial of adrulipase, yeast-derived enzyme for EPI Article 10 March
Cystic Fibrosis News Today: 1st CF patient screened Phase 2 trial of adrulipase to treat EPI Article 07 February
Cystic Fibrosis News Today: Patient Screening to Begin for Phase 2 Trial of Adrulipase Article 02 February
First Wave BioPharma Presentation – Sequire Biotechnology Conference ‘23 Video 02 February
Clinical Trials Arena: First Wave BioPharma to initiate trial of Adrulipase for Cystic Fibrosis Article 01 February
Scrip Asks…What Does 2023 Hold For Biopharma? Part 3: Global Headwinds Article 13 January

 
2022

TitleFormatDate
Sequire Spotlight Presents First Wave BioPharma (FWBI): Clinical Stage Biopharmaceuticals Video 22 December
Life Science Leader magazine interviews James Sapirstein Article 01 December
Impact Wealth: Impacting The BioPharma Industry With James Sapirstein Article 04 November
Fierce Biotech: First Wave signs up Rho for phase 2 trial of gastrointestinal drug Article 03 November
Cystic Fibrosis News Today: First Wave, Rho Team Up to Test New Adrulipase Treatment for CF Article 02 November
The Top 100 Innovators and Entrepreneurs Magazine Interviews James Sapirstein Article 25 October
Toni Loudenbeck of Traders News Source Interviews James Sapirstein CEO, First Wave BioPharma, Inc. Audio 6 October
Clinical Trial Guru interviews James Sapirstein Video 23 September
The Big Biz Show – Bob “Sully” Sullivan interviews James Sapirstein Video 08 September
The Big Biz Show – Bob “Sully” Sullivan interviews James Sapirstein Video 30 August
The Big Biz Show – Bob “Sully” Sullivan interviews James Sapirstein Video 14 June
The Big Biz Show – Bob “Sully” Sullivan interviews James Sapirstein Video 29 April
Medscape Education Issues Presentation on: “The Gastrointestinal System and COVID-19” Presentation 22 April
The Big Biz Show – Bob “Sully” Sullivan interviews James Sapirstein Video 01 April
Global Business Reports – interview with James Sapirstein Article 22 March
BioTuesdays – First Wave developing targeted, non-systemic therapies for GI diseases Article 22 March
The Big Biz Show – Bob “Sully” Sullivan interviews James Sapirstein Video 01 March
U.S. Pharmaceutical Industry Newsletter Article 18 February
Health Professional Radio: “Phase 2 RESERVOIR Study for COVID-GI Symptoms"  Podcast  09 February 
Health Professional Radio: “Phase 2 RESERVOIR Study for COVID-GI Symptoms"  Podcast  09 February 
The Big Biz Show – Bob “Sully” Sullivan interviews James Sapirstein  Video  27 January 
The Big Biz Show – Bob “Sully” Sullivan interviews James Sapirstein  Video  19 January 
New to the Street: Jane King Interviews James Sapirstein  Video  17 January 
The Bio Report – Repurposing A Drug For Parasitic Infections As A Targeted GI Therapy  Podcast  13 January 
First Wave BioPharma Files Two Provisional US Patent Applications For Adrulipase – Benzinga  Article  13 January 
EXCLUSIVE: First Wave BioPharma CEO Talks COVID-19 Trial – Benzinga  Article/Video  06 January 
The Big Biz Show – Bob “Sully” Sullivan interviews James Sapirstein  Video 06 January 
2021

TitleFormatDate
The Big Biz Show – Bob “Sully” Sullivan interviews James Sapirstein Video 02 December 
The Clinical Research Circle – Dan Sfera interviews James Sapirstein Video 19 October 
The Big Biz Show – Bob “Sully” Sullivan interviews James Sapirstein Video 12 October 
New to the Street: Jayne King interviews James Sapirstein Video 01 October 
The Big Biz Show – Bob “Sully” Sullivan interviews James Sapirstein Video 28 September 
AzurRx to Acquire First Wave Bio for $229m Article 14 September 
AzurRx Carves Out Slice of IBD Market in $229 Million Buyout | BioSpace Article 13 September 
AzurRx boosts GI pipeline through First Wave buyout worth up to $229M | FierceBiotech Article 13 September 
Serial entrepreneur Gary Glick sells another one of his startups for $290M — this time to an unlikely buyer – Endpoints News (endpts.com) Article 13 September 
AzurRx BioPharma Acquires First Wave Bio Inc. - Contract Pharma Article 13 September 
AzurRx Carves Out Slice of IBD Market in $229 Million Buyout Article 13 September 
AzurRx boosts GI pipeline through First Wave buyout worth up to $229M Article  13 September
The Big Biz Show – Bob “Sully” Sullivan interviews James Sapirstein Video 07 September 
The Big Biz Show – Bob “Sully” Sullivan interviews James Sapirstein Video 12 August 
The Big Biz Show – Bob “Sully” Sullivan interviews James Sapirstein Video 26 July 
National Public Radio (NPR) – KERA: Sam Baker interviews AzurRx COVID-GI clinical trial principal investigator Dr. Salma Saiger – “It’s Not Just A Respiratory Disease: How COVID Can Impact Your Gut” Podcast 19 July 
The Clinical Trials Guru – with Dan Sfera and James Sa Video 09 July 
Enhancing Human Life – with James Sapirstein and James Pennington Video 22 June 
New to the Street Video 13 June 
Healthcheck (WFAA-ABC Dallas/Ft. Worth): Sonia Azad discusses COVID-GI infections and the AzurRx Reservoir clinical trial with Dr. Salma Saiger Video 10 June 
The Big Biz ShowThe Big Biz Show - Bob “Sully” Sullivan interviews James Sapirstein Video 10 June 
Enhancing Human Life - with James Sapirstein and Douglas Jensen Video 9 June
Enhancing Human Life - with James Sapirstein and Douglas Jensen Podcast 9 June
WBAP/KLIF Dallas: Katrina Boonzaier interviews Dr. Salma Saiger about COVID-GI infections and the initiation of AzurRx’s Reservoir clinical trial. Article 4 June
The Big Biz Show - Bob “Sully” Sullivan interviews James Sapirstein Video 17 May
Investor Summit Group Q2 Virtual Summit Video 17 May
New to the Street Video  14 May
The Big Biz Show Video 3 May
Global Business Reports Article 24 March
H.C. Wainwright Fireside Chat Video 22 March
The Fly Article 15 March
Health Professional Radio: “COVID-19 Infections of the GI Tract and the Long Haul Phenomenon” Podcast 8 March
Attacking COVID-19 Virus Hiding in the Gastrointestinal Tract of Long-Haulers with James Sapirstein AzurRx BioPharma on Empowered Patient Podcast with Karen Jagoda Podcast 15 February

 
2020

TitleFormatDate
 Newsmax ” National Report” with Shaun Kraisman & Emma Rechenberg  Video  30 December 
 Newsmax “American Agenda” with Bob Sellers  Video 29 December 
 Stock2Me Podcast Featuring AzurRx Biopharma Inc. President & CEO James Sapirstein   Podcast 24 November 
 NTD “America is Talking” with Cindy Drukier  Video  12 November 
 TD Ameritrade Network “The Watch List” with Shawn Cruz   Video 02 November 
The Richmond Club Video 20 June
U.S. Biopharmaceuticals 2020 Report Article 4 June
Stock News Now (SNN) Live Video 19 May
Innovators with Jane King (LilaMax Media) Video 18 May
AzurRx Biopharma in the Age of COVID-19 - Q&A with CEO James Sapirstein - April 21, 2020 Video 21 April
logo ICO

CONTACT

777 Yamato Road Suite 502
Boca Raton, FL 33431
(561) 589-7020
info@firstwavebio.com

SOCIAL MEDIA